These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 27878832)
1. Prenatal cfDNA screening results indicative of maternal neoplasm: survey of current practice and management needs. Giles ME; Murphy L; Krstić N; Sullivan C; Hashmi SS; Stevens B Prenat Diagn; 2017 Feb; 37(2):126-132. PubMed ID: 27878832 [TBL] [Abstract][Full Text] [Related]
2. NIPT: current utilization and implications for the future of prenatal genetic counseling. Buchanan A; Sachs A; Toler T; Tsipis J Prenat Diagn; 2014 Sep; 34(9):850-7. PubMed ID: 24711206 [TBL] [Abstract][Full Text] [Related]
3. The use of noninvasive prenatal testing in obstetric care: educational resources, practice patterns, and barriers reported by a national sample of clinicians. Farrell RM; Agatisa PK; Mercer MB; Mitchum AG; Coleridge MB Prenat Diagn; 2016 Jun; 36(6):499-506. PubMed ID: 26991091 [TBL] [Abstract][Full Text] [Related]
4. Talking about disability in prenatal genetic counseling: a report of two interactive workshops. Hodgson J; Weil J J Genet Couns; 2012 Feb; 21(1):17-23. PubMed ID: 22037895 [TBL] [Abstract][Full Text] [Related]
5. An exploration of genetic counselors' needs and experiences with prenatal chromosomal microarray testing. Bernhardt BA; Kellom K; Barbarese A; Faucett WA; Wapner RJ J Genet Couns; 2014 Dec; 23(6):938-47. PubMed ID: 24569858 [TBL] [Abstract][Full Text] [Related]
6. The impact of insurance coverage on the prenatal genetic counseling process: An exploration of genetic counselors' experiences with TRICARE. Brown J; O'Neill S; DiNonno W; Hess O Prenat Diagn; 2019 May; 39(6):448-455. PubMed ID: 30883831 [TBL] [Abstract][Full Text] [Related]
7. The Integration of Noninvasive Prenatal Screening into the Existing Prenatal Paradigm: a Survey of Current Genetic Counseling Practice. Suskin E; Hercher L; Aaron KE; Bajaj K J Genet Couns; 2016 Oct; 25(5):1032-43. PubMed ID: 26879922 [TBL] [Abstract][Full Text] [Related]
8. Presymptomatic Identification of Cancers in Pregnant Women During Noninvasive Prenatal Testing. Amant F; Verheecke M; Wlodarska I; Dehaspe L; Brady P; Brison N; Van Den Bogaert K; Dierickx D; Vandecaveye V; Tousseyn T; Moerman P; Vanderstichele A; Vergote I; Neven P; Berteloot P; Putseys K; Danneels L; Vandenberghe P; Legius E; Vermeesch JR JAMA Oncol; 2015 Sep; 1(6):814-9. PubMed ID: 26355862 [TBL] [Abstract][Full Text] [Related]
9. Genetic Counselors' Perspectives About Cell-Free DNA: Experiences, Challenges, and Expectations for Obstetricians. Agatisa PK; Mercer MB; Coleridge M; Farrell RM J Genet Couns; 2018 Dec; 27(6):1374-1385. PubMed ID: 29951719 [TBL] [Abstract][Full Text] [Related]
10. [Utterly unanticipated findings]. Jordan B Med Sci (Paris); 2015 May; 31(5):567-8. PubMed ID: 26059309 [TBL] [Abstract][Full Text] [Related]
11. Noninvasive prenatal testing/noninvasive prenatal diagnosis: the position of the National Society of Genetic Counselors. Devers PL; Cronister A; Ormond KE; Facio F; Brasington CK; Flodman P J Genet Couns; 2013 Jun; 22(3):291-5. PubMed ID: 23334531 [TBL] [Abstract][Full Text] [Related]
12. Maternal Plasma DNA and RNA Sequencing for Prenatal Testing. Tamminga S; van Maarle M; Henneman L; Oudejans CB; Cornel MC; Sistermans EA Adv Clin Chem; 2016; 74():63-102. PubMed ID: 27117661 [TBL] [Abstract][Full Text] [Related]
13. Molecular testing for cystic fibrosis carrier status practice guidelines: recommendations of the National Society of Genetic Counselors. Langfelder-Schwind E; Karczeski B; Strecker MN; Redman J; Sugarman EA; Zaleski C; Brown T; Keiles S; Powers A; Ghate S; Darrah R J Genet Couns; 2014 Feb; 23(1):5-15. PubMed ID: 24014130 [TBL] [Abstract][Full Text] [Related]
14. Heterogeneity in testing practices for infections during pregnancy: national survey across Switzerland. Aebi-Popp K; Kahlert C; Rauch A; Mosimann B; Baud D; Low N; Surbek D Swiss Med Wkly; 2016; 146():w14325. PubMed ID: 27399957 [TBL] [Abstract][Full Text] [Related]
15. Implementing Group Prenatal Counseling for Expanded Noninvasive Screening Options. Gammon BL; Otto L; Wick M; Borowski K; Allyse M J Genet Couns; 2018 Aug; 27(4):894-901. PubMed ID: 29247311 [TBL] [Abstract][Full Text] [Related]
16. Comparing genetic counselor's and patient's perceptions of needs in prenatal chromosomal microarray testing. Walser SA; Kellom KS; Palmer SC; Bernhardt BA Prenat Diagn; 2015 Sep; 35(9):870-8. PubMed ID: 25995037 [TBL] [Abstract][Full Text] [Related]
17. Australasian genetic counselors' attitudes toward disability and prenatal testing: Findings from a cross-sectional survey. Yanes T; Nathan V; Wallingford C; Faragher R; Nankervis K; Jacobs C; Vassos M; Boyle F; Carroll A; Smith S; McInerney-Leo A J Genet Couns; 2024 Aug; 33(4):822-833. PubMed ID: 37735951 [TBL] [Abstract][Full Text] [Related]
18. Emerging issues in invasive prenatal diagnosis: Safety and competency in the post-NIPT era. Hui L; The S; McCarthy EA; Walker SP Aust N Z J Obstet Gynaecol; 2015 Dec; 55(6):541-6. PubMed ID: 26303213 [TBL] [Abstract][Full Text] [Related]
19. A survey of genetic counselors' use of informed consent documents for prenatal genetic counseling sessions. Jacobson GM; Veach PM; LeRoy BS J Genet Couns; 2001 Feb; 10(1):3-24. PubMed ID: 11767800 [TBL] [Abstract][Full Text] [Related]
20. Incidental Detection of Maternal Neoplasia in Noninvasive Prenatal Testing. Dharajiya NG; Grosu DS; Farkas DH; McCullough RM; Almasri E; Sun Y; Kim SK; Jensen TJ; Saldivar JS; Topol EJ; van den Boom D; Ehrich M Clin Chem; 2018 Feb; 64(2):329-335. PubMed ID: 28982650 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]